H Davis

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. pmc Cost of hospitalizations associated with sickle cell disease in the United States
    H Davis
    Office of Epidemiology and Biostatistics, Food and Drug Administration, Rockville, MD 20857, USA
    Public Health Rep 112:40-3. 1997
  2. pmc Geographic differences in mortality of young children with sickle cell disease in the United States
    H Davis
    Office of Epidemiology and Biostatistics, Food and Drug Administration, Rockville MD 20857, USA
    Public Health Rep 112:52-8. 1997
  3. ncbi request reprint The risk for outpatient antibiotic-treated infections following a course of oral corticosteroids among children with asthma
    H Davis
    Office of Epidemiology and Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, USA
    J Asthma 35:419-25. 1998
  4. ncbi request reprint Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons
    A C Scallet
    Division of Neurotoxicology, NCTR FDA, Jefferson, Arkansas 72079, USA
    Toxicol Sci 81:364-70. 2004

Detail Information

Publications4

  1. pmc Cost of hospitalizations associated with sickle cell disease in the United States
    H Davis
    Office of Epidemiology and Biostatistics, Food and Drug Administration, Rockville, MD 20857, USA
    Public Health Rep 112:40-3. 1997
    ..This study estimated the number and cost of hospitalizations associated with sickle cell disease in the United States...
  2. pmc Geographic differences in mortality of young children with sickle cell disease in the United States
    H Davis
    Office of Epidemiology and Biostatistics, Food and Drug Administration, Rockville MD 20857, USA
    Public Health Rep 112:52-8. 1997
    ..This study's objective was to identify areas in the United States where young children with sickle cell disease are at especially high and low risk of dying...
  3. ncbi request reprint The risk for outpatient antibiotic-treated infections following a course of oral corticosteroids among children with asthma
    H Davis
    Office of Epidemiology and Biostatistics, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20857, USA
    J Asthma 35:419-25. 1998
    ..65 (95% CI 0.53-0.97). We conclude that one course of oral corticosteroids does not increase asthmatic children's risk for infections treated with outpatient antibiotics...
  4. ncbi request reprint Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons
    A C Scallet
    Division of Neurotoxicology, NCTR FDA, Jefferson, Arkansas 72079, USA
    Toxicol Sci 81:364-70. 2004
    ....